Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

Related Articles by Review for PubMed (Select 12011482)

1.

Prediction of compound signature using high density gene expression profiling.

Hamadeh HK, Bushel PR, Jayadev S, DiSorbo O, Bennett L, Li L, Tennant R, Stoll R, Barrett JC, Paules RS, Blanchard K, Afshari CA.

Toxicol Sci. 2002 Jun;67(2):232-40.

2.

Gene expression analysis reveals chemical-specific profiles.

Morgan KT.

Toxicol Sci. 2002 Jun;67(2):155-6. Review.

3.

[Transcriptomes for serial analysis of gene expression].

Marti J, Piquemal D, Manchon L, Commes T.

J Soc Biol. 2002;196(4):303-7. Review. French.

PMID:
12645300
4.

Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes.

Rushmore TH, Kong AN.

Curr Drug Metab. 2002 Oct;3(5):481-90. Review.

PMID:
12369894
5.

Drug-induced oxidative stress in rat liver from a toxicogenomics perspective.

McMillian M, Nie A, Parker JB, Leone A, Kemmerer M, Bryant S, Herlich J, Yieh L, Bittner A, Liu X, Wan J, Johnson MD, Lord P.

Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):171-8. Review.

PMID:
15982685
6.

Toxicogenomic approach for assessing toxicant-related disease.

Waters MD, Olden K, Tennant RW.

Mutat Res. 2003 Nov;544(2-3):415-24. Review.

PMID:
14644344
7.

Toxicogenomics in the assessment of immunotoxicity.

Baken KA, Vandebriel RJ, Pennings JL, Kleinjans JC, van Loveren H.

Methods. 2007 Jan;41(1):132-41. Review.

PMID:
17161310
8.

Genes and environment - striking the fine balance between sophisticated biomonitoring and true functional environmental genomics.

Steinberg CE, St├╝rzenbaum SR, Menzel R.

Sci Total Environ. 2008 Aug 1;400(1-3):142-61. doi: 10.1016/j.scitotenv.2008.07.023. Epub 2008 Sep 24. Review.

PMID:
18817948
9.

Analysis of altered genomic expression profiles in the senescent and diseased myocardium using cDNA microarrays.

Juhasz O, Zhu Y, Garg R, Anisimov SV, Boheler KR.

Eur J Heart Fail. 2002 Dec;4(6):687-97. Review.

PMID:
12453538
10.

Functional genomics approaches to understanding brain disorders.

Shilling PD, Kelsoe JR.

Pharmacogenomics. 2002 Jan;3(1):31-45. Review.

PMID:
11966401
11.

Expression genomics and drug development: towards predictive pharmacology.

Liu ET.

Brief Funct Genomic Proteomic. 2005 Feb;3(4):303-21. Review.

12.

Application of DNA microarrays in pharmacogenomics and toxicogenomics.

Chin KV, Kong AN.

Pharm Res. 2002 Dec;19(12):1773-8. Review.

PMID:
12523654
13.

DNA microarrays: an overview of technologies and applications to toxicology.

Zarbl H.

Curr Protoc Toxicol. 2001;Chapter 1:Unit1.4. doi: 10.1002/0471140856.tx0104s09. Review.

PMID:
23045022
14.

Large-scale gene expression analysis in molecular target discovery.

Orr MS, Scherf U.

Leukemia. 2002 Apr;16(4):473-7. Review.

15.

Protein therapeutics: promises and challenges for the 21st century.

Weng Z, DeLisi C.

Trends Biotechnol. 2002 Jan;20(1):29-35. Review.

PMID:
11742675
16.

Toxicogenomic analysis methods for predictive toxicology.

Maggioli J, Hoover A, Weng L.

J Pharmacol Toxicol Methods. 2006 Jan-Feb;53(1):31-7. Epub 2005 Oct 19. Review.

PMID:
16236530
17.

Using genomics to understand intestinal biology.

Fleet JC.

J Physiol Biochem. 2007 Mar;63(1):83-96. Review.

PMID:
17722646
18.

Analysis and simulation of gene expression profiles in pure and mixed cell populations.

Hebenstreit D, Teichmann SA.

Phys Biol. 2011 Jun;8(3):035013. doi: 10.1088/1478-3975/8/3/035013. Epub 2011 May 13. Review.

PMID:
21572174
19.

The Comparative Toxicogenomics Database (CTD): a resource for comparative toxicological studies.

Mattingly CJ, Rosenstein MC, Colby GT, Forrest JN Jr, Boyer JL.

J Exp Zool A Comp Exp Biol. 2006 Sep 1;305(9):689-92. Review.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk